Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,079 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ABO Blood Incompatibility Positively Affects Early Graft Function: Single-Center Retrospective Cohort Study.
Watari S, Araki M, Wada K, Yoshinaga K, Maruyama Y, Mitsui Y, Sadahira T, Kubota R, Nishimura S, Kobayashi Y, Takeuchi H, Tanabe K, Kitagawa M, Morinaga H, Kitamura S, Sugiyama H, Wada J, Watanabe M, Watanabe T, Nasu Y. Watari S, et al. Among authors: tanabe k. Transplant Proc. 2021 Jun;53(5):1494-1500. doi: 10.1016/j.transproceed.2021.03.043. Epub 2021 Apr 28. Transplant Proc. 2021. PMID: 33931247 Free article.
Intermittent administration of a sustained-release prostacyclin analog ONO-1301 ameliorates renal alterations in a rat type 1 diabetes model.
Yamasaki H, Maeshima Y, Nasu T, Saito D, Tanabe K, Hirokoshi-Kawahara K, Sugiyama H, Sakai Y, Makino H. Yamasaki H, et al. Among authors: tanabe k. Prostaglandins Leukot Essent Fatty Acids. 2011 Mar-Apr;84(3-4):99-107. doi: 10.1016/j.plefa.2010.11.005. Epub 2010 Dec 21. Prostaglandins Leukot Essent Fatty Acids. 2011. PMID: 21177088
Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis.
Saito D, Maeshima Y, Nasu T, Yamasaki H, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H. Saito D, et al. Among authors: tanabe k. Am J Physiol Renal Physiol. 2011 Apr;300(4):F873-86. doi: 10.1152/ajprenal.00503.2010. Epub 2011 Jan 12. Am J Physiol Renal Physiol. 2011. PMID: 21228103 Free article.
We recently reported the therapeutic effects of vasohibin-1 (VASH-1), an endogenous angiogenesis inhibitor, in a type 1 diabetic nephropathy model (Nasu T, Maeshima Y, Kinomura M, Hirokoshi-Kawahara K, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H. Diabete …
We recently reported the therapeutic effects of vasohibin-1 (VASH-1), an endogenous angiogenesis inhibitor, in a type 1 diabetic nephropathy …
The Efficacy of Rituximab in High-risk Renal Transplant Recipients.
Araki M, Wada K, Mitsui Y, Kubota R, Yoshioka T, Ariyoshi Y, Kobayashi Y, Kitagawa M, Tanabe K, Sugiyama H, Wada J, Watanabe M, Watanabe T, Hotta K, Nasu Y. Araki M, et al. Among authors: tanabe k. Acta Med Okayama. 2016 Aug;70(4):295-7. doi: 10.18926/AMO/54507. Acta Med Okayama. 2016. PMID: 27549676 Free article.
3,079 results